BIO-GENE TECHNOLOGY LTD - Announcements

Market Cap $8.859M Add to my watchlist

Bio-Gene Technology Limited is an Australia-based agriculture technology development... Bio-Gene Technology Limited is an Australia-based agriculture technology development company enabling the next generation of novel insecticides derived from nature to achieve high impact globally. Its technology is based on compounds with a novel mode of action proven to overcome insecticide resistance with minimal impact on human health and the environment. The Company’s technology provides multiple potential new solutions in applications across crop protection, grain storage, public health, and consumer products. It is developing and commercialising a broad portfolio of targeted insect control and pest management solutions. The Company's lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a chemically synthesized product based on flavesone. Qcide is a natural oil product containing tasmanone as the active constituent. The Company operates in one business segment, being the conduct of research and development activities in the agricultural sector.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BGT	BGT Shareholder Newsletter and Teleconference		27/03/19		Share
BGT	Change of Director's Interest Notice - D Brumley		04/03/19		Share
BGT	Change of Director's Interest Notice - R Klupacs		28/02/19		Share
BGT	Appendix 4D - Half Yearly Report and Accounts - 31/12/18	PRICE SENSITIVE	20/02/19		Share
BGT	Appendix 4C - 31 December 2018	PRICE SENSITIVE	31/01/19		Share
BGT	BIO-GENE EXPANDS RESEARCH PROGRAM FOR QCIDE	PRICE SENSITIVE	13/12/18		Share
BGT	Change of Director's Interest Notice - P May		06/12/18		Share
BGT	Change of Director's Interest Notice - R Jagger		06/12/18		Share
BGT	Appendix 3B		06/12/18		Share
BGT	Expiry of Listed Options		20/11/18		Share
BGT	Results of Meeting - 2018 AGM		20/11/18		Share
BGT	2018 AGM - CEO Presentation		20/11/18		Share
BGT	Appendix 4C - 30 September 2018	PRICE SENSITIVE	25/10/18		Share
BGT	Notice of Annual General Meeting/Proxy Form		16/10/18		Share
BGT	Change of Registered Office		15/10/18		Share
BGT	Company Update Presentation - October 2018		15/10/18		Share
BGT	IMPROVED MANUFACTURING PROCESS FOR FLAVOCIDE	PRICE SENSITIVE	11/10/18		Share
BGT	POSITIVE RESULTS FROM 28-DAY TOXICOLOGY STUDY ON FLAVOCIDE	PRICE SENSITIVE	09/10/18		Share
BGT	Appendix 3B - Release of Shares from Escrow		02/10/18		Share
BGT	Change of Registry Address: Automic P/L - Sydney Office		28/09/18		Share
BGT	Upcoming Release of Shares from Escrow		14/09/18		Share
BGT	POSITIVE RESULTS FOR FLAVOCIDE IN INITIAL FIELD TESTING	PRICE SENSITIVE	12/09/18		Share
BGT	POSITIVE EFFICACY RESULTS FOR FLAVOCIDE IN NEW PEST TYPES	PRICE SENSITIVE	05/09/18		Share
BGT	BGT 2018 Corporate Governance Statement		23/08/18		Share
BGT	Appendix 4G - 2018		23/08/18		Share
BGT	BGT 2018 Appendix 4E and Annual Report	PRICE SENSITIVE	23/08/18		Share
BGT	Appendix 3B - Release of Shares from Escrow		26/07/18	409.36KB	Share
BGT	Appendix 4C - 30 June 2018	PRICE SENSITIVE	26/07/18	398.95KB	Share
BGT	POSITIVE RESULTS FOR FLAVOCIDE IN SAFETY STUDY	PRICE SENSITIVE	23/07/18	258.13KB	Share
BGT	BIO-GENE SUBMITS TWO NEW INTERNATIONAL PATENT APPLICATIONS	PRICE SENSITIVE	10/07/18	250.11KB	Share
BGT	Qcide advancement - new results and research collaboration	PRICE SENSITIVE	03/07/18	285.36KB	Share
BGT	Upcoming Release of Shares from Escrow		29/06/18	217.87KB	Share
BGT	Appendix 3B - Release of Shares from Escrow		29/06/18	716.68KB	Share
BGT	EXPANSION OF FLAVOCIDE MODE OF ACTION STUDIES	PRICE SENSITIVE	26/06/18	280.67KB	Share
BGT	BEE SAFETY STUDY DELIVERS POSITIVE FINDINGS FOR FLAVOCIDE	PRICE SENSITIVE	18/06/18	254.49KB	Share
BGT	Upcoming Release of Shares from Escrow		13/06/18	217.98KB	Share
BGT	POSITIVE RESULTS WITH FLAVOCIDE VS. GRAIN STORAGE PESTS	PRICE SENSITIVE	28/05/18	308.71KB	Share
BGT	UPCOMING RELEASE OF SHARES FROM ESCROW		11/05/18		Share
BGT	Appendix 4C - 31 March 2018	PRICE SENSITIVE	30/04/18		Share
BGT	POSITIVE EFFICACY TEST AGAINST ANOTHER MAJOR CROP PEST	PRICE SENSITIVE	26/04/18		Share
BGT	MANUFACTURING PROJECT WITH CSIRO ADVANCES TO STAGE 3	PRICE SENSITIVE	17/04/18		Share
BGT	POSITIVE RESULT IN EFFICACY TEST WITH MAJOR CEREAL CROP PEST	PRICE SENSITIVE	09/04/18		Share
BGT	Appendix 3B - Release of Shares from Escrow		27/03/18		Share
BGT	POSITIVE RESULTS FOR FLAVOCIDE WITH MAJOR RICE PEST	PRICE SENSITIVE	26/03/18		Share
BGT	Bio-Gene Investor Conference Call - 26 March 2018		23/03/18		Share
BGT	ANIMAL HEALTH TESTING AND COLLABORATION UPDATE	PRICE SENSITIVE	21/03/18		Share
BGT	Appendix 3B - Loyalty Options		08/03/18		Share
BGT	UPCOMING RELEASE OF SHARES FROM ESCROW		07/03/18		Share
BGT	Prospectus for Loyalty Options Lodged		01/03/18		Share
BGT	Letter to Optionholders		01/03/18		Share
BGT	Letter to Ineligible Shareholders		01/03/18		Share
BGT	Appendix 3B - Loyalty Options		01/03/18		Share
BGT	Prospectus for Loyalty Options	PRICE SENSITIVE	01/03/18		Share
BGT	Appendix 3B		23/02/18		Share
BGT	LOYALTY OPTIONS UPDATE		20/02/18		Share
BGT	KEY APPOINTMENTS TO ADVISORY & MANAGEMENT TEAMS		14/02/18		Share
BGT	Appendix 4D - Half Yearly Report and Accounts - 31/12/17	PRICE SENSITIVE	08/02/18		Share
BGT	UPCOMING RELEASE OF SHARES FROM ESCROW		06/02/18		Share
BGT	Pilot study shows Flavocide activity against mosquitos	PRICE SENSITIVE	31/01/18		Share
BGT	Appendix 4C - December 2017	PRICE SENSITIVE	30/01/18		Share
BGT	BIO-GENE 2018 GOALS & OBJECTIVES FOLLOWING SUCCESSFUL IPO	PRICE SENSITIVE	21/12/17		Share
BGT	BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS	PRICE SENSITIVE	19/12/17		Share
BGT	BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS	PRICE SENSITIVE	11/12/17		Share
BGT	BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR		04/12/17		Share
BGT	Appendix 3B		04/12/17		Share
BGT	BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF		01/12/17		Share
BGT	BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO	PRICE SENSITIVE	30/11/17		Share
BGT	BIO-GENE COMPLETES $7.1M IPO TO LIST ON ASX		29/11/17		Share
BGT	Becoming a substantial holder		29/11/17		Share
BGT	Bio-Gene Investor Briefing		29/11/17		Share
BGT	Initial Director's Interest Notice - P May		29/11/17		Share
BGT	Initial Director's Interest Notice - K Rumble		29/11/17		Share
BGT	Initial Director's Interest Notice - R Klupacs		29/11/17		Share
BGT	Initial Director's Interest Notice - R Jagger		29/11/17		Share
BGT	Initial Director's Interest Notice - D Brumley		29/11/17		Share
BGT	Corporate Governance Statement		28/11/17		Share
BGT	Updated Top 20		28/11/17		Share
BGT	Company Pre-Quotation Disclosure		27/11/17		Share
BGT	Securities Trading Policy		27/11/17		Share
BGT	Pro-Forma Statement of Financial Statement		27/11/17		Share
BGT	Loan Share Plan Rules		27/11/17		Share
BGT	Full Year Audited Accounts 30 June 2017		27/11/17		Share
BGT	Full Year Audited Accounts 30 June 2016		27/11/17		Share
BGT	Top 20		27/11/17		Share
BGT	Distribution Schedule		27/11/17		Share
BGT	Constitution		27/11/17		Share
BGT	Prospectus		27/11/17		Share
BGT	Appendix 1A and Information Form and Checklist		27/11/17		Share
BGT	Market Release - PQD		27/11/17		Share
BGT	Market Release - Admission	PRICE SENSITIVE	27/11/17		Share
BGT	ASX Notice - Admission and Quotation		27/11/17		Share

BGT BGT Shareholder Newsletter and Teleconference
27/03/19			Share
BGT Change of Director's Interest Notice - D Brumley
04/03/19			Share
BGT Change of Director's Interest Notice - R Klupacs
28/02/19			Share
BGT Appendix 4D - Half Yearly Report and Accounts - 31/12/18
20/02/19	PRICE SENSITIVE		Share
BGT Appendix 4C - 31 December 2018
31/01/19	PRICE SENSITIVE		Share
BGT BIO-GENE EXPANDS RESEARCH PROGRAM FOR QCIDE
13/12/18	PRICE SENSITIVE		Share
BGT Change of Director's Interest Notice - P May
06/12/18			Share
BGT Change of Director's Interest Notice - R Jagger
06/12/18			Share
BGT Appendix 3B
06/12/18			Share
BGT Expiry of Listed Options
20/11/18			Share
BGT Results of Meeting - 2018 AGM
20/11/18			Share
BGT 2018 AGM - CEO Presentation
20/11/18			Share
BGT Appendix 4C - 30 September 2018
25/10/18	PRICE SENSITIVE		Share
BGT Notice of Annual General Meeting/Proxy Form
16/10/18			Share
BGT Change of Registered Office
15/10/18			Share
BGT Company Update Presentation - October 2018
15/10/18			Share
BGT IMPROVED MANUFACTURING PROCESS FOR FLAVOCIDE
11/10/18	PRICE SENSITIVE		Share
BGT POSITIVE RESULTS FROM 28-DAY TOXICOLOGY STUDY ON FLAVOCIDE
09/10/18	PRICE SENSITIVE		Share
BGT Appendix 3B - Release of Shares from Escrow
02/10/18			Share
BGT Change of Registry Address: Automic P/L - Sydney Office
28/09/18			Share
BGT Upcoming Release of Shares from Escrow
14/09/18			Share
BGT POSITIVE RESULTS FOR FLAVOCIDE IN INITIAL FIELD TESTING
12/09/18	PRICE SENSITIVE		Share
BGT POSITIVE EFFICACY RESULTS FOR FLAVOCIDE IN NEW PEST TYPES
05/09/18	PRICE SENSITIVE		Share
BGT BGT 2018 Corporate Governance Statement
23/08/18			Share
BGT Appendix 4G - 2018
23/08/18			Share
BGT BGT 2018 Appendix 4E and Annual Report
23/08/18	PRICE SENSITIVE		Share
BGT Appendix 3B - Release of Shares from Escrow
26/07/18		409.36KB	Share
BGT Appendix 4C - 30 June 2018
26/07/18	PRICE SENSITIVE	398.95KB	Share
BGT POSITIVE RESULTS FOR FLAVOCIDE IN SAFETY STUDY
23/07/18	PRICE SENSITIVE	258.13KB	Share
BGT BIO-GENE SUBMITS TWO NEW INTERNATIONAL PATENT APPLICATIONS
10/07/18	PRICE SENSITIVE	250.11KB	Share
BGT Qcide advancement - new results and research collaboration
03/07/18	PRICE SENSITIVE	285.36KB	Share
BGT Upcoming Release of Shares from Escrow
29/06/18		217.87KB	Share
BGT Appendix 3B - Release of Shares from Escrow
29/06/18		716.68KB	Share
BGT EXPANSION OF FLAVOCIDE MODE OF ACTION STUDIES
26/06/18	PRICE SENSITIVE	280.67KB	Share
BGT BEE SAFETY STUDY DELIVERS POSITIVE FINDINGS FOR FLAVOCIDE
18/06/18	PRICE SENSITIVE	254.49KB	Share
BGT Upcoming Release of Shares from Escrow
13/06/18		217.98KB	Share
BGT POSITIVE RESULTS WITH FLAVOCIDE VS. GRAIN STORAGE PESTS
28/05/18	PRICE SENSITIVE	308.71KB	Share
BGT UPCOMING RELEASE OF SHARES FROM ESCROW
11/05/18			Share
BGT Appendix 4C - 31 March 2018
30/04/18	PRICE SENSITIVE		Share
BGT POSITIVE EFFICACY TEST AGAINST ANOTHER MAJOR CROP PEST
26/04/18	PRICE SENSITIVE		Share
BGT MANUFACTURING PROJECT WITH CSIRO ADVANCES TO STAGE 3
17/04/18	PRICE SENSITIVE		Share
BGT POSITIVE RESULT IN EFFICACY TEST WITH MAJOR CEREAL CROP PEST
09/04/18	PRICE SENSITIVE		Share
BGT Appendix 3B - Release of Shares from Escrow
27/03/18			Share
BGT POSITIVE RESULTS FOR FLAVOCIDE WITH MAJOR RICE PEST
26/03/18	PRICE SENSITIVE		Share
BGT Bio-Gene Investor Conference Call - 26 March 2018
23/03/18			Share
BGT ANIMAL HEALTH TESTING AND COLLABORATION UPDATE
21/03/18	PRICE SENSITIVE		Share
BGT Appendix 3B - Loyalty Options
08/03/18			Share
BGT UPCOMING RELEASE OF SHARES FROM ESCROW
07/03/18			Share
BGT Prospectus for Loyalty Options Lodged
01/03/18			Share
BGT Letter to Optionholders
01/03/18			Share
BGT Letter to Ineligible Shareholders
01/03/18			Share
BGT Appendix 3B - Loyalty Options
01/03/18			Share
BGT Prospectus for Loyalty Options
01/03/18	PRICE SENSITIVE		Share
BGT Appendix 3B
23/02/18			Share
BGT LOYALTY OPTIONS UPDATE
20/02/18			Share
BGT KEY APPOINTMENTS TO ADVISORY & MANAGEMENT TEAMS
14/02/18			Share
BGT Appendix 4D - Half Yearly Report and Accounts - 31/12/17
08/02/18	PRICE SENSITIVE		Share
BGT UPCOMING RELEASE OF SHARES FROM ESCROW
06/02/18			Share
BGT Pilot study shows Flavocide activity against mosquitos
31/01/18	PRICE SENSITIVE		Share
BGT Appendix 4C - December 2017
30/01/18	PRICE SENSITIVE		Share
BGT BIO-GENE 2018 GOALS & OBJECTIVES FOLLOWING SUCCESSFUL IPO
21/12/17	PRICE SENSITIVE		Share
BGT BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS
19/12/17	PRICE SENSITIVE		Share
BGT BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS
11/12/17	PRICE SENSITIVE		Share
BGT BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR
04/12/17			Share
BGT Appendix 3B
04/12/17			Share
BGT BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF
01/12/17			Share
BGT BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO
30/11/17	PRICE SENSITIVE		Share
BGT BIO-GENE COMPLETES $7.1M IPO TO LIST ON ASX
29/11/17			Share
BGT Becoming a substantial holder
29/11/17			Share
BGT Bio-Gene Investor Briefing
29/11/17			Share
BGT Initial Director's Interest Notice - P May
29/11/17			Share
BGT Initial Director's Interest Notice - K Rumble
29/11/17			Share
BGT Initial Director's Interest Notice - R Klupacs
29/11/17			Share
BGT Initial Director's Interest Notice - R Jagger
29/11/17			Share
BGT Initial Director's Interest Notice - D Brumley
29/11/17			Share
BGT Corporate Governance Statement
28/11/17			Share
BGT Updated Top 20
28/11/17			Share
BGT Company Pre-Quotation Disclosure
27/11/17			Share
BGT Securities Trading Policy
27/11/17			Share
BGT Pro-Forma Statement of Financial Statement
27/11/17			Share
BGT Loan Share Plan Rules
27/11/17			Share
BGT Full Year Audited Accounts 30 June 2017
27/11/17			Share
BGT Full Year Audited Accounts 30 June 2016
27/11/17			Share
BGT Top 20
27/11/17			Share
BGT Distribution Schedule
27/11/17			Share
BGT Constitution
27/11/17			Share
BGT Prospectus
27/11/17			Share
BGT Appendix 1A and Information Form and Checklist
27/11/17			Share
BGT Market Release - PQD
27/11/17			Share
BGT Market Release - Admission
27/11/17	PRICE SENSITIVE		Share
BGT ASX Notice - Admission and Quotation
27/11/17			Share

REFRESH

(20min delay)
Last 4.4¢		Change 0.001(2.33%)		Mkt cap ! $8.859M

Open	High	Low	Value	Volume
4.4¢	4.4¢	4.4¢	$5	112

Buyers (Bids)

No.	Vol.	Price($)
1	20000	4.2¢

Sellers (Offers)

Price($)	Vol.	No.
4.5¢	12375	1

View Market Depth

No.	Vol.	Price($)
1	8563	0.044
1	100000	0.039
1	118000	0.038
1	120050	0.037
1	64000	0.029

Price($)	Vol.	No.
0.048	30000	1
0.053	11511	1
0.054	59999	2
0.055	118498	1
0.061	225000	2

Last trade - 10.00am 29/11/2024 (20 minute delay)

BGT (ASX) Chart